Suresh established the pre-clinical facilities for Syngene-BBRC Biocon, in Bangalore and at BMS, Redwood City, California, USA. He has excelled at NIH and BMS winning the NIH Director’s award and BMS Galaxy Award for Leadership in Science. Prior to NIH, Suresh worked at St. Jude Children’s Cancer Research Hospital, Memphis, was a resident at University of Maryland and taught in a medical school.

Suresh graduated with a Veterinary Science degree from A P Agricultural University, Tirupati, in 1986, and earned a Masters in Microbiology and Immunology from the same university.  He received his PhD from Iowa State University, USA in 1994.

He is the first council member on AAALAC International from India.  He is on the executive council board of The Federation of Asian Biotech Association – FABA.  He is also a member on several other organizations that promote research in Medicine and Biotechnology.  He has published thirty scientific papers in reputed journal including Nature, PNAS, Immunology, PLOS etc., He speaks at several international forums and platforms on Science and Leadership.  Suresh also initiated the annual international conference on 3R Advances and Alternatives which attracts several reputed speakers, and was invited by the World Congress in 2023.

He is building the research eco-system in India and aspires to create more entrepreneurs and start-ups, thereby creating innovative thinkers in Biology and Medicine.  Acasta Health the startup of Suresh which works on creating a biomarker based Biological Age and Healthspan assessment platform, researching on aging degenerative conditions for biologic therapeutics and was awaded the 2024 Healthcare Company of the year award and Successpreneur awards apart from being nominated as the Top 10 Startups by Pharma Outlook for 2023.